Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 2/20 | 0.32 |
| ▸ | LDHB | P07195 | 2/20 | 0.32 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
| ▸ | VCP | P55072 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24323721 | 0.97 | LDHA (0.36) | LDHALDHBKDM4C | |
| SCHEMBL24298775 | 0.96 | LDHA (0.35) | LDHALDHBKDM4C | |
| SCHEMBL24324172 | 0.96 | LDHA (0.35) | LDHALDHBKDM4C | |
| SCHEMBL26569626 | 0.92 | — | — | |
| SCHEMBL24323694 | 0.92 | LDHA (0.31) | LDHALDHBNR1H4 | |
| SCHEMBL24298776 | 0.90 | — | — | |
| SCHEMBL24324641 | 0.89 | CYP1A2 (0.31) | LDHALDHBMEN1NPC1ALDH1A1 | |
| SCHEMBL26572133 | 0.89 | GPR84 (0.37) | MEN1ALDH1A1RAB9AKMT2ASMN1; SMN2 | |
| SCHEMBL24298810 | 0.87 | AAK1 (0.34) | LDHALDHBNR1H4MEN1NPC1 | |
| SCHEMBL22509294 | 0.87 | AAK1 (0.34) | LDHALDHBNR1H4MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076622-A2 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |